SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-127706
Filing Date
2018-04-24
Accepted
2018-04-24 07:35:32
Documents
6
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A d549092ddefa14a.htm DEFA14A 35723
2 GRAPHIC g5490922a.jpg GRAPHIC 2392
3 GRAPHIC g549092naa1.jpg GRAPHIC 1171
4 GRAPHIC g549092naa2.jpg GRAPHIC 1184
5 GRAPHIC g549092naa3.jpg GRAPHIC 1188
6 GRAPHIC g549092naa4.jpg GRAPHIC 1177
  Complete submission text file 0001193125-18-127706.txt   47435
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37449 | Film No.: 18770133
SIC: 2834 Pharmaceutical Preparations